We are live on ! Find out more
CDLX icon

Cardlytics
CDLX

53 hedge funds and large institutions have $217M invested in Cardlytics in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 10

54% more capital invested

Capital invested by funds: $141M → $217M (+$76.4M)

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

4% more funds holding

Funds holding: 51 → 53 (+2)

0.09% more ownership

Funds ownership: 4.87% → 4.97% (+0.09%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
24
Reduced
10
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.51M
2
DCM
Driehaus Capital Management
Illinois
+$4.04M
3
FCM
Frontier Capital Management
Massachusetts
+$4.03M
4
GIPM
G2 Investment Partners Management
New York
+$3.44M
5
BlackRock
BlackRock
New York
+$2.2M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$5.85M
2
ECP
Empyrean Capital Partners
California
-$2.95M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.51M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.42M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
PIA
51
Piedmont Investment Advisors
North Carolina
$2K +$1.85K +10 New
Bank of Montreal
52
Bank of Montreal
Ontario, Canada
$1K +$740 +4 New
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K +$1.11K +6 New
Federated Hermes
54
Federated Hermes
Pennsylvania
– -$5.85M -40,000 Closed
ECP
55
Empyrean Capital Partners
California
– -$2.95M -20,178 Closed
HI
56
HBK Investments
Texas
– -$878K -6,000 Closed
LCM
57
Landscape Capital Management
New Jersey
– -$666K -4,556 Closed
DIM
58
DC Investments Management
Virginia
– -$438K -2,992 Closed
Goldman Sachs
59
Goldman Sachs
New York
– -$315K -2,156 Closed
CSS
60
Cubist Systematic Strategies
Connecticut
– -$267K -1,828 Closed
VF
61
Virtu Financial
New York
– -$215K -1,466 Closed
SO
62
STRS Ohio
Ohio
– -$21K -150 Closed
TRCT
63
Tower Research Capital (TRC)
New York
– -$4K -27 Closed
PHK
64
Point72 Hong Kong
Hong Kong
– -$1K -9 Closed
BCA
65
Bay Colony Advisors
Massachusetts
– +$185 +1 New
1 2
3

CDLX Hedge Fund Activity: Q2 2018 in Review

53 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2018, worth a combined $217M — up 54% from $141M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CDLX positions and 11 closed out — a net gain of 2 holders — while 24 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $8.51M. The largest seller was Federated Hermes, exiting entirely with an estimated $5.85M sold.

  • 53 institutional investors held Cardlytics (CDLX) as of Q2 2018, up from 51 in Q1 2018.
  • Funds reported $217M of Cardlytics stock for Q2 2018, up 54% quarter-over-quarter.
  • 13 funds opened new Cardlytics positions in Q2 2018 and 11 closed out, a net change of +2 holders.
  • The largest Cardlytics buyer in Q2 2018 was Fidelity Investments, an estimated $8.51M added.
  • The largest Cardlytics seller in Q2 2018 was Federated Hermes, an estimated $5.85M sold.

Based on aggregated 13F filings for Q2 2018.